This early-stage study is testing a new oral medication called AUTX-703 for adults with advanced forms of blood cancer (AML or MDS) that have returned or stopped responding to other treatments. The main goal is to find a safe dose and see how the body handles the drug. Researcher…
Phase: PHASE1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC